| [1］Aljarbou AN.The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia［J］.Int J Health Sci(Qassim)，2013，7(3)：333-340. [2］Hajarizadeh B，Grebely J，Dore GJ.Epidemiology and natural history of HCV infection［J］.Nat Rev Gastroenterol Hepatol，2013，10(9)：553-562. [3］谭德明，宋琳.丙型肝炎并发肝外疾病干扰素应用进展［J］.中国实用内科杂志，2007，27(1)：65-68. [4］Himoto T，Masaki T.Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection［J］.Clin Dev Immunol,2012,2012：871401. [5］Stasi R，Chia LW，Kalkur P，et al.Pathobiology and treatment of hepatitis virus-related thrombocytopenia［J］.Mediterr J Hematol Infect Dis,2009，1(3)：e2009023. [6］Louie KS，Micallef JM，Pimenta JM，et al.Prevalence of thrombocytopenia among patients with chronic hepatitis C：a systematic review［J］.J Viral Hepat，2011，18(1)：1-7. [7］Tejima K，Masuzaki R，Ikeda H，et al.Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly［J］.J Gastroenterol,2010，45(8)：876-884. [8］Aref S，Ibrahem L，El Menshawy N，et al.Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia［J］.Hematology,2012，17(2)：118-121. [9］Dimitroulis D，Valsami S，Stamopoulos P，et al.Immunological HCV-associated thrombocytopenia：short review［J］.Clin Dev Immunol,2012,2012：378653. [10］Olariu M，Olariu C，Olteanu D.Thrombocytopenia in chronic hepatitis C［J］.J Gastrointestin Liver Dis,2010，19(4)：381-385. [11］石雁梅，兰英华，单蕾，等.乙型肝炎病毒感染时的骨髓造血干细胞［J］.临床肝胆病杂志,2010，26(4)：377-380. [12］Onan E，Uskudar O，Coskun Y，et al.Higher hepatitis C virus concentration in platelets than in plasma in a patient with ITP［J］.Platelets,2012，23(5)：413-414. [13］Wong CH，Jenne CN，Petri B，et al.Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance［J］.Nat Immunol，2013，14(8)：785-792. [14］Kondo R，Yano H，Nakashima O，et al.Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C［J］.J Gastroenterol,2013，48(4)：526-534. [15］杨仁池.糖皮质激素治疗血液疾病临床经验［J］.中国实用内科杂志，2013，33(10)：779-781. [16］Provan D，Stasi R，Newland AC，et al.International consensus report on the investigation and management of primary immune thrombocytopenia［J］.Blood，2010，115(2)：168-186. [17］Dufour JF，Pradat P，Ruivard M，et al.Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection：clinical description of 16 cases［J］.Eur J Gastroenterol Hepatol，2009，21(3)：245-253. [18］Kee KM，Wang JH，Hung CH，et al.Improvement of thrombocytopenia in hepatitis C-related advanced fibrosis patients after sustained virological response［J］.Dig Dis Sci,2013，58(2)：556-561. [19］Kawaguchi T，Komori A，Seike M，et al.Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia：a randomized，open-label，phase Ⅱ study［J］.J Gastroenterol,2012，47(12)：1342-1351. [20］Aguilar C.Potential usefulness of thrombopoietin receptor agonists in haemophiliacs with thrombocytopaenia due to chronic liver disease［J］.Blood Coagul Fibrinolysis，2013，24(3)：231-236. |
